CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 34 enrolled
Drug / intervention
glycogen loading +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04416204
NCT04416204N/ACompleted

Role of Hepatic Glycogen on Nocturnal EGP in T2D

University of Alabama at Birmingham·interventional·Posted Jun 4, 2020·Updated Mar 1, 2024

In Brief

A clinical study evaluating glycogen loading and No Glycogen Loading for Diabetes Mellitus and Diabetes Mellitus, Type 2. Completed, enrolled 34 participants across 1 site.

Detailed Summary

The experimental approach in this study intends to investigate the role of hepatic glycogen content on nocturnal regulation of endogenous glucose production including the relative contributions of glycogenolysis and gluconeogenesis and the extent to which this differs between subjects with type 2 diabetes and subjects without diabetes. Both participants with type 2 diabetes and participants without diabetes will be studied after consuming either a low carbohydrate (no glycogen loading) or high carbohydrate (glycogen loading) diet.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJun 4, 2020
Enrollment StartAug 21, 2020
Primary CompletionAug 15, 2022
Study CompletionFeb 15, 2023
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 6.1 years ago

Interventions

glycogen loadingother

Subjects will consume an isocaloric diet \[60% carbs, 20% protein, 20% fat (33 kcal/kg/day)\] for 3 days prior to the overnight study.

No Glycogen Loadingother

Subjects will consume an isocaloric diet \[40% carbs, 20% protein, 40% fat (33 kcal/kg/day)\] for 3 days prior to the overnight study.